Description
A VCP modulator; inhibits VCP ATPase activity (IC50 = 330 nM); inhibits tunicamycin-induced cell death, ATP depletion, and upregulation of CHOP in HeLa cells at 20, 50, and 50 μM, respectively; inhibits OGD-induced ATP depletion and cell death in rat primary cortical neurons in an in vitro model of cerebral ischemia at 100 μM; reduces infarction volume and increases the latency to fall in an accelerating rotarod test in a mouse model of focal cerebral ischemia induced by transient distal MCAO at 100 mg/kg immediately following occlusion and again at 50 mg/kg following reperfusion; inhibits thinning of the retinal outer nuclear layer and preserves visual function in an rd10 mouse model of retinitis pigmentosa at 50 mg/kg
Formal name: 4-amino-3-[2-[6-(4-fluoro-2-methylphenyl)-3-pyridinyl]diazenyl]-1-naphthalenesulfonic acid, monosodium salt
Synonyms:
Molecular weight: 458.4
CAS: 1357164-52-3
Purity: ≥98%
Formulation: A crystalline solid